tradingkey.logo

Firefly Neuroscience Inc

AIFF
View Detailed Chart

2.600USD

+0.030+1.17%
Market hours ETQuotes delayed by 15 min
34.58MMarket Cap
LossP/E TTM

Firefly Neuroscience Inc

2.600

+0.030+1.17%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.17%

5 Days

-6.14%

1 Month

-13.33%

6 Months

-66.62%

Year to Date

-1.89%

1 Year

-53.24%

View Detailed Chart

Agency Rating

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(9)
Neutral(2)
Buy(1)
Indicators
Sell(3)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.038
Sell
RSI(14)
37.115
Neutral
STOCH(KDJ)(9,3,3)
21.952
Neutral
ATR(14)
0.120
Low Volatility
CCI(14)
-211.262
Oversold
Williams %R
70.582
Sell
TRIX(12,20)
-0.357
Sell
StochRSI(14)
36.297
Buy
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
2.650
Sell
MA10
2.731
Sell
MA20
2.765
Sell
MA50
2.893
Sell
MA100
3.068
Sell
MA200
3.504
Sell

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company dedicated to developing neuroscientific solutions that enhance outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics (BNA) software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder (ADHD). BNA, utilizing AI and an extensive proprietary electroencephalogram (EEG) database, combines the automatic analysis of Event Related Potentials (ERPs), spectral EEG and behavioral performance data for a comprehensive, and objective data-driven brain health evaluation. The BNA Platform, in conjunction with an FDA-cleared EEG system, can provide clinicians with comprehensive insights into brain function (cognition).
Ticker SymbolAIFF
CompanyFirefly Neuroscience Inc
CEOMr. Greg Lipschitz
Websitehttps://fireflyneuro.com/
KeyAI